Researchers have known for decades that stress contributes to heart disease. But a new analysis by researchers at Duke Medicine shows mental stress may tax women’s hearts more than men’s. The research appears online Oct. 13, 2014, in the Journal of the American College of Cardiology.
Scientists at The Scripps Research Institute have created a synthetic molecule that mimics “good” cholesterol and have shown it can reduce plaque buildup in the arteries of animal models. The molecule, taken orally, improved cholesterol in just two weeks.
Rates of out-of-hospital cardiac arrest are elevated after days with high levels of air pollutants, reports a Japanese study in the October Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).
The disease, which has been named "Chronic Atrial Intestinal Dysrhythmia syndrome" (CAID), is a serious condition caused by a rare genetic mutation. This finding demonstrates that heart and guts rhythmic contractions are closely linked by a single gene in the human body, as shown in a study published on October 5, 2014 in Nature Genetics.
Ohio State University researchers are testing an experimental app linked to an electronic health record (EHR) to give patients and physicians a whole new way of looking at cardiovascular disease risk - literally. Scientists are hoping that by turning vitals into visuals, the app will spark conversation, motivate change and improve health.
– A new genetic finding from Duke Medicine suggests that some people who are prone to hostility, anxiety and depression might also be hard-wired to gain weight when exposed to chronic stress, leading to diabetes and heart disease.
Findings emphasize the need to develop a standardized surveillance system for non-communicable diseases, such as CVD, cancer and lung diseases, by ethnic group in Canada
People with diabetes who appear otherwise healthy may have a six-fold higher risk of developing heart failure regardless of their cholesterol levels, new Johns Hopkins Bloomberg School of Public Health research suggests.
A team of investigators from the University of Kentucky has made a thought-provoking discovery about a type of cholesterol previously believed to be a "bad guy" in the development of heart disease and other conditions.
New research shows a novel polypill increases patient adherence to treatment following a myocardial infarction (MI) or heart attack, according to new study results reported at the European Society of Cardiology’s ESC Congress 2014 in Barcelona, Spain by Principal Investigator Valentin Fuster, MD, PhD.
The research shows that for better heart health, rich countries should continue to deliver high quality health care while trying to reduce risk factors, while poor countries need to avoid the rise of risk factors but also substantially improve their health care.
• Calcium build-up in the coronary artery walls was more useful for correctly predicting kidney disease patients’ risk of heart disease than other measures of atherosclerosis such as thickness of the carotid artery walls and narrowing of the arteries in the legs.
A study from UT Southwestern Medical Center researchers found that recently introduced cholesterol guidelines would significantly reduce new cardiovascular events, when compared to treatment based on previous cholesterol guidelines.
According to recommendations resulting from a multidisciplinary conference sponsored by the National Institutes of Health, scientists and physicians in low- and middle-income countries should build on existing HIV research to study and treat chronic conditions.
Recent Baylor Research Institute research shows that significant consumption of instant noodles – ramen included – may increase a person’s risk for cardiometabolic syndrome, especially in women.
Researchers discover a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure.
Easing heart palpitations is one benefit of catheter ablation. A longer life span is another. Study shows 60 drop in cardiovascular mortality after successful ablation for atrial fibrillation.
Need an incentive to go for a run? A new Iowa State University study, published in the Journal of the American College of Cardiology, found running for just five to 10 minutes a day can significantly reduce your risk of death from cardiovascular disease.
A new technique for repairing the most common cardiac birth defect in newborns, commonly referred to as “a hole in the heart,” has been used successfully to mend the condition in six premature infants without subjecting the tiny patients to open-heart surgery.
University of Washington bioengineers have a designed a peptide structure that can stop the harmful changes of the body's normal proteins into a state that's linked to widespread diseases such as Alzheimer's, Parkinson's, heart disease, Type 2 diabetes and Lou Gehrig's disease.
A St. Jude Children’s Research Hospital study found that 73 percent of adult survivors of childhood cancer more than doubled their risk of developing metabolic syndrome and related health problems by failing to follow a heart-healthy lifestyle.
There's a "critical need" for research and innovative new strategies to address health disparities and to improve health outcomes across all groups of people with cardiovascular disease, according to a special symposium feature in the August issue of The American Journal of Medical Sciences (AJMS), official journal of the Southern Society for Clinical Investigation (SSCI). The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Bacteria that produce a therapeutic compound in the gut inhibit weight gain, insulin resistance and other adverse effects of a high-fat diet in mice, Vanderbilt University investigators have discovered.
In North Carolina, a stroke survivor, a heart attack survivor, and a heart transplant recipient have teamed up to share their experiences—with the goal of encouraging others to reduce their own cardiovascular disease risks. The "Triad Triage Trio" is featured in the August issue of Heart Insight, a quarterly magazine for patients, their families and caregivers. Heart Insight is published by the American Heart Association (AHA) and Lippincott Williams & Wilkins, part of Wolters Kluwer Health.
Researchers at Washington University School of Medicine in St. Louis and elsewhere argue that medicine focuses too much on fighting diseases individually instead of concentrating on interventions that prevent multiple chronic diseases and extend healthy lifespan. They call for moving forward with strategies that have been shown to delay aging in animals. In addition to promoting a healthy diet and regular exercise, these strategies include manipulating molecular pathways that slow aging and promote healthy longevity.
People with Type 2 diabetes who eat a diet high in salt face twice the risk of developing cardiovascular disease as those who consume less sodium, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
A diet enriched in 18-HEPE might help prevent heart failure in patients with cardiovascular diseases, according to researchers in Japan.
— Researchers at Wayne State University have made a fundamental discovery and, in subsequent collaboration with scientists at La Jolla Institute for Allergy and Immunology (LIAI), are one step closer to the goal of developing the world’s first T-cell peptide-based vaccine for heart disease — the number one killer in the nation.
Instead of going through the groin during heart catheterizations, physicians can now insert the catheter through a patient’s wrist, a less traumatic and safer option for some patients — especially women.
Researchers discover that enzyme involved in intracellular signaling plays a crucial role in developing metabolic syndrome, a finding that has a U of U spinoff company developing a drug to potentially treat the condition.
A new study by New York Institute of Technology's A. Martin Gerdes, Ph.D. draws links between thyroid hormones and cardiac function in patients with diabetes and heart disease. Restoring normal levels of thyroid hormones prevented the progression of heart disease in rats with diabetes.
Loyola University Chicago recently hosted a meeting of more than 60 of the world’s leading researchers of a protein that could hold the key to new treatments for heart disease.
Treatment with the diabetes drug liraglutide, in combination with diet and exercise, led to a significant reduction in weight and improved a number of cardiovascular risk factors, including high blood pressure and high cholesterol, according to a multicenter study. The results, from more than 3,700 overweight and obese nondiabetic adults, were presented Saturday at the joint meeting of the International Society of Endocrinology and the Endocrine Society: ICE/ENDO 2014 in Chicago.
Research toward the world’s first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing in mice.
Stem cell therapy for cardiovascular disease isn’t a medical pipe dream – it’s a reality today, although patients need to better understand the complex science behind these experimental treatments, according to the chief of Cardiology for the Cedars-Sinai Heart Institute.
Rheumatoid arthritis patients overall are twice as likely as the average person to develop heart problems. Pinpointing which rheumatoid arthritis patients need stepped-up heart disease prevention efforts has been a challenge; research by Mayo Clinic and others has found that standard heart disease risk assessment tools may underrate the danger a particular person faces. To better pinpoint rheumatoid arthritis patients’ heart disease risk, an international team that includes Mayo researchers has created a heart disease risk calculator tailored to rheumatoid arthritis.
Doctors at The Ohio State University Wexner Medical Center are the first in the country to begin treating some heart failure patients with a new wireless, implantable hemodynamic monitor that was just approved by the FDA.
Advances in the understanding of the genetics of coronary artery disease, or CAD, will revitalize the field and lead to more therapeutic targets for new medicines to combat this common disease, suggests a genetics expert from the Perelman School of Medicine at the University of Pennsylvania in a Perspective article in the new issue of Science Translational Medicine.
Implantable cardioverter defibrillators (ICDs) are associated with improved survival among heart failure patients whose left ventricles only pump 30 to 35 percent of blood out of the heart with each contraction, according to a study from the Duke Clinical Research Institute.
For otherwise healthy middle-aged women who are overweight or obese, physical activity may be their best option for avoiding heart disease, according to a study that followed nearly 900 women for seven years. These findings were reported in a paper led by authors at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center, the University Hospital for Einstein, and published today in the Journal of Clinical Endocrinology & Metabolism.
The American Medical Group Foundation (AMGF) today announced that three medical groups and health systems in the Washington, DC metropolitan area will participate in the inaugural Measure Up/Pressure Down® National Day of Action: Roll Up Your Sleeves! on May 15, 2014.
Even if treated, hypertension and high cholesterol are increasingly common for people with human immunodeficiency virus (HIV), according to a new study from researchers at Mount Sinai St. Luke’s and Mount Sinai Roosevelt hospitals in New York and the University of California, Davis.
After two decades of arduous research, a National Institutes of Health (NIH)-funded investigator at the Children’s Hospital of Michigan (CHM) at the Detroit Medical Center (DMC) and the Wayne State University School of Medicine has published a new study showing that many children with an often fatal type of heart disease can recover “normal size and function” of damaged sections of their hearts.
Mount Sinai study shows the socioeconomic status of congestive heart failure patients does not influence hospital rankings for heart failure readmissions.
The 2014 Louisville Symposium on Heart Disease in Women, the first of what is planned to be an annual event, will be held Saturday, June 28.
How a person defines their own socioeconomic standing (SES) within their community can help predict their risk of cardiovascular disease, but only among Whites, not Blacks, finds a recent study in Ethnicity and Disease.
Traditional first-line checks of such heart disease risk factors as cholesterol, blood pressure and smoking habits aren’t nearly good enough to identify cardiovascular disease in otherwise healthy, young firefighters, according to results of a small Johns Hopkins study.
A type of cell that builds mouse hearts can renew itself, Johns Hopkins researchers report. They say the discovery, which likely applies to such cells in humans as well, may pave the way to using them to repair hearts damaged by disease — or even grow new heart tissue for transplantation.
People who took statins in the 2009–10 year were consuming more calories and fat than those who used statins 10 years earlier. There was no similar increase in caloric and fat intake among non–stain users during that decade.
An Indiana U. study has bolstered the link between red meat consumption and heart disease by finding a strong association between heme iron, found only in meat, and potentially deadly coronary heart disease.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right